secwatch.observer — SEC 8-K summary
======================================

Issuer:     BRAINSTORM CELL THERAPEUTICS INC. (BCLI)
CIK:        0001137883
Form:       8-K
Filed at:   2025-06-25T23:59:59+00:00
Accession:  0001104659-25-062595
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Brainstorm Cell shareholders approve 2M share increase in equity plan pool
--------------------------------------------------------------------------

- Shareholders approved increasing the shared pool under the 2014 plans by 2M shares, to 2,906,666 shares.
- Vote: 758,668 for, 362,809 against, 2,556,446 broker non-votes for the plan amendments.
- All seven director nominees elected; Dr. Stacy Lindborg received the most votes (1,055,967 for).
- Ratification of Brightman Almagor Zohar & Co. as FY2025 auditor approved (3,346,891 for).
- Approval of warrant share issuance under Nasdaq Rule 5635(d) passed (874,965 for).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1137883/000110465925062595/0001104659-25-062595-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1137883/000110465925062595/tm2518995d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-062595

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer